1. Home
  2. NXRT vs VALN Comparison

NXRT vs VALN Comparison

Compare NXRT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

N/A

Current Price

$21.47

Market Cap

582.3M

Sector

Real Estate

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$6.56

Market Cap

653.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXRT
VALN
Founded
2014
2012
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
582.3M
653.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
NXRT
VALN
Price
$21.47
$6.56
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$31.00
$15.50
AVG Volume (30 Days)
404.9K
28.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$251,281,000.00
N/A
Revenue This Year
$3.09
N/A
Revenue Next Year
$3.02
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.13
$4.75
52 Week High
$33.34
$12.23

Technical Indicators

Market Signals
Indicator
NXRT
VALN
Relative Strength Index (RSI) 28.23 51.11
Support Level N/A $6.29
Resistance Level $24.77 $6.60
Average True Range (ATR) 0.70 0.21
MACD -0.10 -0.09
Stochastic Oscillator 1.26 21.67

Price Performance

Historical Comparison
NXRT
VALN

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. The trust's objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: